Antiviral use for influenza in children has dropped to 52%-59% since the COVID-19 pandemic, causing concern among health experts. Antiviral treatment was more likely in children with underlying ...

Paul Kruszka, MD, MPH, FACMG, chief medical officer of GeneDx, joined us to provide background of whole genome sequencing and its benefits. Paul Kruszka, MD, MPH, FACMG, chief medical officer at ...

Reviewing the AAP's sudden infant death syndrome 2022 guidelines ...

Reviewing the AAP's sudden infant death syndrome 2022 guidelines ...

Reviewing the AAP's sudden infant death syndrome 2022 guidelines ...

Positive, phase 3 data for once-daily JNJ-2113 (icotrokinra) has been announced by Protagonist Therapeutics in collaboration with Johnson & Johnson that demonstrated "significant" skin clearance ...

A further understanding of the role SARS-CoV-2 plays in T2D incidence can add an important component to benefit and risk considerations to prevent COVID-19. In a retrospective cohort study of nearly ...

Reviewing the AAP's sudden infant death syndrome 2022 guidelines ...

Reviewing the AAP's sudden infant death syndrome 2022 guidelines ...

Rakesh Jain, MD, MPH discusses once-daily clonidine hydrochloride (ONYDA XR) for ADHD ...

Rakesh Jain, MD, MPH discusses once-daily clonidine hydrochloride (ONYDA XR) for ADHD ...

Rakesh Jain, MD, MPH discusses once-daily clonidine hydrochloride (ONYDA XR) for ADHD ...